Check out our most popular compounded medications! Get Started
Dehydroepiandrosterone 1%/Levocarnitine 2% Topical Cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. This formulation is used to treat conditions such as adrenal insufficiency, chronic fatigue syndrome, and certain metabolic disorders. The active ingredients are absorbed locally to provide targeted therapeutic effects.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Dehydroepiandrosterone (DHEA) 1% and Levocarnitine 2% Topical Cream is a compounded medication designed for transdermal delivery of active ingredients. Dispensed in a pump mechanism, this semisolid preparation allows for convenient and controlled application on the skin, facilitating localized treatment and optimal absorption of its active components.
DHEA is a naturally occurring steroid hormone produced by the adrenal glands, serving as a precursor to androgens and estrogens, which are vital for various bodily functions. Topical application of DHEA may enhance skin hydration, improve elasticity, and promote collagen synthesis, potentially aiding in the improvement of skin integrity and appearance. It may also have immunomodulatory effects, contributing to skin health.
Levocarnitine, commonly known as L-carnitine, is an amino acid derivative essential for energy production within cells. It facilitates the transport of long-chain fatty acids into the mitochondria, where they are oxidized to produce energy. Topically applied Levocarnitine may help modulate lipid metabolism in the skin, potentially reducing excess sebum production and supporting overall skin health.
The combination of DHEA and Levocarnitine in this formulation aims to synergistically support skin vitality and function. By enhancing cell energy metabolism and promoting healthy skin structure, this cream may be beneficial for individuals seeking to improve skin condition, maintain skin integrity, or address specific dermatological concerns under professional guidance.
Patients using this topical cream should apply it as directed by their healthcare provider, typically to clean, dry skin once or twice daily. It is important to avoid contact with eyes and mucous membranes and to wash hands thoroughly after application. If any irritation or adverse reactions occur, patients should discontinue use and consult their healthcare provider promptly.
Prescribers should consider this compounded formulation for patients who may benefit from the localized effects of DHEA and Levocarnitine. The percentages of active ingredients can be adjusted to meet specific patient needs. It is important to assess each patient's medical history, including any hormonal sensitivities or contraindications, to ensure the safe and appropriate use of this compound.
If you have any questions about this formulation or its suitability for you or your patients, please reach out to us. Our team at Bayview Pharmacy is available to provide further information and support regarding this topical cream.
Dehydroepiandrosterone (DHEA) and Levocarnitine are active ingredients in this topical cream formulation, each with distinct pharmacological properties and potential interactions. DHEA is a steroid hormone that serves as a precursor to androgens and estrogens, while Levocarnitine is an amino acid derivative involved in the metabolism of fatty acids. When used in combination, these compounds may offer therapeutic benefits for conditions such as hormonal imbalances, fatigue, and certain metabolic disorders. However, it is crucial to consider potential drug interactions to ensure safe and appropriate use.
For patients using this topical cream, it is important to be aware of the potential systemic absorption of DHEA, which can interact with other medications. DHEA may enhance the effects of estrogenic or androgenic medications, potentially leading to hormonal imbalances. Patients taking hormone replacement therapies, oral contraceptives, or medications for prostate conditions should consult their healthcare provider before using this cream. Additionally, DHEA may interact with anticoagulants such as warfarin, potentially altering their effectiveness and increasing the risk of bleeding. Regular monitoring of blood coagulation parameters is advised for patients on anticoagulant therapy.
Levocarnitine, while generally well-tolerated, may interact with certain medications. It can enhance the effects of anticoagulants, similar to DHEA, and may also interact with thyroid hormone replacement therapies, potentially requiring dose adjustments. Patients with thyroid disorders should be closely monitored when using this formulation. Furthermore, Levocarnitine may interact with medications that affect renal function, such as certain antibiotics and diuretics, necessitating careful monitoring of renal parameters.
For prescribers, it is essential to evaluate the patient's current medication regimen and medical history to identify potential interactions. Consideration should be given to the patient's hormonal status, coagulation profile, and renal function before prescribing this topical cream. Regular follow-up and monitoring are recommended to assess the therapeutic response and detect any adverse effects or interactions. Adjustments to the patient's medication regimen may be necessary to optimize treatment outcomes.
Patients and prescribers should be aware that while topical application generally results in lower systemic absorption compared to oral administration, the potential for interactions still exists. It is important to apply the cream as directed and avoid excessive use, which could increase systemic exposure. If you have any questions or concerns about using this formulation, please reach out to us at Bayview Pharmacy for further guidance and support.
The Dehydroepiandrosterone (DHEA) 1%/Levocarnitine 2% Topical Cream is a specialized formulation designed to deliver active ingredients directly to the skin for localized treatment or absorption. This semisolid preparation is dispensed through a pump mechanism, ensuring a convenient and controlled application. The formulation leverages the unique properties of both DHEA and Levocarnitine to address specific disease states, providing therapeutic benefits through transdermal delivery.
Dehydroepiandrosterone (DHEA) is a naturally occurring steroid hormone that serves as a precursor to androgens and estrogens, the male and female sex hormones. When applied topically, DHEA can be absorbed through the skin, where it may exert localized effects. It is believed to help in the modulation of immune function, skin hydration, and elasticity, potentially benefiting conditions associated with hormonal imbalances or deficiencies. By restoring DHEA levels in the skin, this formulation may aid in improving skin health and addressing symptoms related to aging or hormonal disorders.
Levocarnitine, also known as L-carnitine, is an amino acid derivative that plays a crucial role in energy metabolism. It facilitates the transport of fatty acids into the mitochondria, where they are oxidized to produce energy. Topically applied Levocarnitine can penetrate the skin barrier and may enhance cellular energy production, which is particularly beneficial in conditions characterized by impaired energy metabolism or muscle function. Additionally, Levocarnitine has been shown to possess antioxidant properties, which can help protect the skin from oxidative stress and inflammation.
The combination of DHEA and Levocarnitine in this topical cream is designed to provide synergistic effects, targeting multiple pathways to improve skin health and address specific disease states. The formulation is particularly useful for patients who may benefit from localized hormone supplementation and enhanced energy metabolism. The pump mechanism ensures precise dosing and minimizes waste, making it an efficient option for both patients and prescribers.
For patients and prescribers considering this formulation, it is important to understand the potential benefits and mechanisms of action of the active ingredients. The topical application allows for targeted treatment, reducing systemic exposure and potential side effects associated with oral administration. As with any compounded medication, it is essential to follow the prescribed dosing regimen and consult with healthcare professionals regarding any concerns or questions.
If you have any questions or need further information about the Dehydroepiandrosterone 1%/Levocarnitine 2% Topical Cream, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries you may have.
This topical cream is used for localized treatment or absorption of active ingredients, potentially aiding in skin health, energy metabolism, and other therapeutic benefits associated with Dehydroepiandrosterone (DHEA) and Levocarnitine.
Apply the cream to clean, dry skin using the pump mechanism for a controlled amount. Gently massage the cream into the skin until fully absorbed. Follow your healthcare provider's instructions regarding the specific area and frequency of application.
Consult with your healthcare provider before applying the cream to your face, as the skin on the face can be more sensitive. They can provide guidance based on your specific skin type and condition.
Some users may experience mild skin irritation, redness, or itching at the application site. If you experience severe reactions or persistent discomfort, discontinue use and consult your healthcare provider.
Store the cream at room temperature, away from direct sunlight and moisture. Keep the pump mechanism tightly closed when not in use to maintain the cream's efficacy and prevent contamination.
If you are pregnant or breastfeeding, consult your healthcare provider before using this topical cream to ensure it is safe for you and your baby.
Results can vary depending on the individual and the condition being treated. Some users may notice improvements within a few weeks, while others may require longer use. Consistent application as directed is key to achieving the best results.
While the cream is generally suitable for most skin types, individuals with sensitive skin should perform a patch test before full application. If you have specific skin concerns, consult your healthcare provider for personalized advice.
You can use other skincare products, but it is advisable to apply the Dehydroepiandrosterone 1%/Levocarnitine 2% Topical Cream first and allow it to fully absorb before applying additional products. This ensures optimal absorption of the active ingredients.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and resume your regular application schedule. Do not apply extra cream to make up for a missed dose.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
